骨化三醇作为类固醇激素维生素 D 的最具生物活性的代谢产物，抑制骨化三醇会导致抗癌药物的作用降低。
Cas No.:32222-06-3
Sample solution is provided at 25 µL, 10mM.
_1-3.$$$39978408@51.jpg');)
_1-9.$$$38538795@65.jpg');)
_1-9.$$$39112701@51.jpg');)
_1-7.$$$37316672@70.jpg');)
_366-372.$$$36198801@70.jpg');)
.$$$38565142@65.jpg');)
_1867-1883.$$$33248023@67.jpg');)
_eads6055.$$$39977546@45.jpg');)
_eadm9805.$$$40080571@45.jpg');)
_eadj3020.$$$39666821@45.jpg');)
_1-20.$$$39757301@28.jpg');)
_1-24.$$$38898113@28.jpg');)
_273-287.$$$36806353@46.jpg');)
_1-16.$$$37156877@44.jpg');)
_1-19.$$$37460805@44.jpg');)
_1291-1307.$$$34518654@46.jpg');)
Calcitriol, as the most biologically active metabolite derived from the secosteroid hormone vitamin D, the inhibition of calcitriol caused decreased effects of anticancer drugs.[1]
In vitro efficacy test it shown that weekly oral administration of calcitriol allowed reach the peak serum calcitriol concentrations well above 1 nM, a concentration that inhibition more than 50% of prostate cancer proliferation. [2] With 10 nM calcitriol remarkably decreased RAGE protein expression and increased sRAGE concentrations in HL-1 cardiomyocytes compared with control cells.[3] Calcitriol exhibited antiproliferative effects against T47D, MCF-7, and MDA-MB-231 with IC50 values in the range of 0.05-0.25 μM.[4] In addition, calcitriol inhibits melanoma cell proliferation with an IC?? of 0.24 μM.[5] BT-474 cells were dose-dependently growth-inhibited by calcitriol with IC50 of 2.9 nM. With 1 nM Calcitriol synergistically improved AZD4547 antiproliferative effects, allowing a 2-fold AZD4547 dose-reduction. [6]
In vivo test it demonstrated that calcitriol (0.03 μg/kg) 5 times/wk intraperitoneally for 10 wk in UNX ApoE-/- mice caused significant vascular calcification and elevated expression of related proteins (BMP2, RANKL, and Runx2).[8] With 0.5 ug/day calcitriol orally improved insulin resistance and HOMA-β after 6 months in ND patients, however, only improved HOMA-β in the dialysis patients, with no obvious effect on insulin resistance.[7]
References:
[1]Ma J, et al. The mechanism of calcitriol in cancer prevention and treatment. Curr Med Chem. 2013;20(33):4121-30.?
[2]Beer TM. Development of weekly high-dose calcitriol based therapy for prostate cancer. Urol Oncol. 2003 Sep-Oct;21(5):399-405.?
[3]Lee TW, et al. ADAM10 modulates calcitriol-regulated RAGE in cardiomyocytes. Eur J Clin Invest. 2017 Sep;47(9):675-683.
[4]Aljunidee KA, et al. Combination therapy of calcitriol inhibits the proliferation of breast cancer cells: new concept of nonclassical function of calcitriol. Horm Mol Biol Clin Investig. 2021 Nov 15.?
[5]Sutedja EK, et al. Calcitriol Inhibits Proliferation and Potentially Induces Apoptosis in B16-F10 Cells. Med Sci Monit Basic Res. 2022 May 5;28:e935139.
? [6]Morales-Guadarrama G, et al. AZD4547 and calcitriol synergistically inhibited BT-474 cell proliferation while modified stemness and tumorsphere formation. J Steroid Biochem Mol Biol. 2022 May 31;223:106132.
[7]Lu Y, et al. Effects of active vitamin D on insulin resistance and islet β-cell function in non-diabetic chronic kidney disease patients: a randomized controlled study. Int Urol Nephrol. 2022 Jul;54(7):1725-1732.
[8]Becker LE, et al. Effect of paricalcitol and calcitriol on aortic wall remodeling in uninephrectomized ApoE knockout mice. Am J Physiol Renal Physiol. 2011 Mar;300(3):F772-82.
骨化三醇作为类固醇激素维生素 D 的最具生物活性的代谢产物,抑制骨化三醇会导致抗癌药物的作用降低。[1]
体外功效测试表明,每周口服骨化三醇可使血清骨化三醇浓度达到峰值,远高于 1 nM,该浓度可抑制超过 50% 的前列腺癌增殖。 [2] 与对照细胞相比,10 nM 骨化三醇可显着降低 HL-1 心肌细胞中 RAGE 蛋白的表达并增加 sRAGE 浓度。[3] 骨化三醇对 T47D、 MCF-7 和 MDA-MB-231 的 IC50 值在 0.05-0.25 μM 范围内。 [4]此外,骨化三醇抑制黑色素瘤细胞增殖,IC50 为 0.24 μM。[5] BT-474 细胞的生长受到剂量依赖性抑制,IC50 为 2.9 nM。与 1 nM 骨化三醇协同改善 AZD4547 的抗增殖作用,使 AZD4547 剂量减少 2 倍。 [6]
体内试验表明,在 UNX ApoE-/- 小鼠中,骨化三醇 (0.03 μg/kg) 腹腔注射 5 次/周,持续 10 周,导致显着的血管钙化和相关蛋白（BMP2、RANKL 和 Runx2）的表达升高。 [8] ND患者口服0.5 ug/天骨化三醇6个月后可改善胰岛素抵抗和HOMA-β,但仅改善透析患者的HOMA-β,对胰岛素抵抗无明显影响.[7]
| Cell experiment [1]: | |
|
Cell lines |
HL-1 cells |
|
Preparation Method |
Calcitriol (1 and 10 nM) was used to treat HL-1 cells for 48 h to determine the initial dose-response effect. To study the functional relevance of FGFR1 modulation, recombinant mouse FGF-2 (25 ng/mL) was administrated (for 0.5 or 48 h) in control and calcitriol-treated HL-1 cells. |
|
Reaction Conditions |
1 and 10 nM; 48 h |
|
Applications |
Compared to control cells, as shown in Fig. 1a, calcitriol (1 and 10 nM) dose-dependently reduced FGFR1 protein expression in HL-1 cells by 31 and 62%, respectively. Similarly, calcitriol (10 nM)-treated HL-1 cells had lower FGFR1 mRNA expression than did control HL-1 cells. |
| Animal experiment [2]: | |
|
Animal models |
Male C57BL/6J mice aged 4–5 weeks and weighing ~21–27 g |
|
Preparation Method |
Four groups of mice (n = 11 each) were maintained on either low-fat diet (LFD) or high-fat diet (HFD) with and without 150 IU/kg/day calcitriol orally for 16 weeks. |
|
Dosage form |
150 IU/kg/day; orally |
|
Applications |
A significant gradual decrease in weight was observed in HFD-fed mice treated with calcitriol compared with a steady increase in controls. Furthermore, calcitriol treatment reduced concentrations of various inflammatory markers including TNF-α, CRP and IL-6. |
|
References: [1]. Lee TW, et al. Calcitriol downregulates fibroblast growth factor receptor 1 through histone deacetylase activation in HL-1 atrial myocytes. J Biomed Sci. 2018 May 18;25(1):42. [2]. Alkharfy KM, et al. Calcitriol attenuates weight-related systemic inflammation and ultrastructural changes in the liver in a rodent model. Basic Clin Pharmacol Toxicol. 2013 Jan;112(1):42-9. |
|
| Cas No. | 32222-06-3 | SDF | |
| 别名 | 骨化三醇; 1,25-Dihydroxyvitamin D3 | ||
| 化学名 | (1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol | ||
| Canonical SMILES | CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C | ||
| 分子式 | C27H44O3 | 分子量 | 416.64 |
| 溶解度 | ≥ 20.832mg/mL in DMSO | 储存条件 | -20°C, protect from light, stored under nitrogen,unstable in solution, ready to use. |
| Shipping Condition | 评估样品解决方案：配备蓝冰进行发货。所有其他可用尺寸：配备RT，或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
 |
1 mg | 5 mg | 10 mg |
| 1 mM | 2.4002 mL | 12.0008 mL | 24.0015 mL |
| 5 mM | 480 μL | 2.4002 mL | 4.8003 mL |
| 10 mM | 240 μL | 1.2001 mL | 2.4002 mL |
| 第一步：请输入基本实验信息（考虑到实验过程中的损耗，建议多配一只动物的药量） | ||||||||||
| 给药剂量 | mg/kg |  |
动物平均体重 | g | |
每只动物给药体积 | ul | |
动物数量 | 只 |
| 第二步：请输入动物体内配方组成（配方适用于不溶于水的药物；不同批次药物配方比例不同，请联系GLPBIO为您提供正确的澄清溶液配方） | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度： mg/ml；
DMSO母液配制方法： mg 药物溶于 μL DMSO溶液（母液浓度 mg/mL，
体内配方配制方法：取 μL DMSO母液，加入 μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入 μL saline，混匀澄清。
1. 首先保证母液是澄清的；
2.
一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >99.00% Appearance: A solid
- COA (Certificate of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
-
Related Biological Data
VD reduces ferroptosis induced by high glucose in HK-2 cells and down-regulation of Klotho attenuates the protective effect of VD on ferroptosis in HK-2 cells. (F-K) Protein levels of SLC7A11, GPX4, TFR1, Klotho and p53 were detected by western blot.
HG + VD group (30 mmol/L D-glucose + 10 nmol/L 1,25(OH)2D3);1,25(OH)2D3 (GLPBIO, Beijing, China) was pretreated for 2 h before intervention.
Apoptosis (2024): 1-13. PMID: 38558206 IF: 7.2002 -
Related Biological Data
Effect of vitamin D deficiency on migration of human trophoblast cells. D&E: Cell migration was measured using wound-healing assay. After 12 and 24 h migration, the scratches were photographed and wounded areas were calculated.
And calcitriol (GLPBIO, China) was dissolved in DMSO at the final concentration of 1 mM, and the final concentration of calcitriol were 0.1 μM.
Placenta (2022). PMID: 36103800 IF: 3.2867